|
000
| 00947nas 2200229za 4500 |
|---|
| 001 | 9.514728 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210615082910 |
|---|
| 007 | ta |
|---|
| 008 | 150406c1990||||xxc|| m #||||f| |0eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-2/1E |
|---|
| 110 | 1 |aCanada.|bHealth Canada. |bDrugs Directorate. |
|---|
| 245 | 10|aDrugs Directorate guidelines |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |
|---|
| 520 | 3 |aDeveloped by the Drugs Directorate of the Health Protection Branch to guide drug manufacturers through the various levels of the approval process. Amendment service supplied for each section by Standing Order. |
|---|
| 563 | |aLoose-leaf |
|---|
| 775 | 08|tDrugs Directorate guidelines / |w(CaOODSP)9.509398 |
|---|
| 775 | 08|tDirectives de la Direction des médicaments / |w(CaOODSP)9.509399 |
|---|
| 775 | 08|tDirectives de la Direction des médicaments |w(CaOODSP)9.513088 |
|---|
| 776 | 0#|tDrugs Directorate guidelines |w(CaOODSP)9.808752 |
|---|